Synthetic sialyl glycolipids (sialo-cholesterol and sialo-diglyceride) induce granulocytic differentiation of human myelogenous leukemia cell line HL-60. 1990

M Saito, and H Nojiri, and H Ogino, and A Yuo, and H Ogura, and M Itoh, and K Tomita, and T Ogawa, and Y Nagai, and S Kitagawa
Division of Hemopoiesis, Jichi Medical School, Tochigi, Japan.

When HL-60 cells were cultivated with synthetic sialyl glycolipids, sialo-cholesterol and sialo-diglyceride, the cells were found to be differentiated into mature granulocytes on morphological and functional criteria. The differentiation of cells was accompanied by inhibition of cell proliferation. The differentiation-inducing activity of sialo-cholesterol was greater than that of sialo-diglyceride on a molar basis, and the alpha-anomer of each compound was more potent than the beta-anomer, suggesting that the stereospecific structure of the compounds is important for the differentiation-inducing activity.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D004950 Esterases Any member of the class of enzymes that catalyze the cleavage of an ester bond and result in the addition of water to the resulting molecules. Esterase
D006017 Glycolipids Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage) Glycolipid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

M Saito, and H Nojiri, and H Ogino, and A Yuo, and H Ogura, and M Itoh, and K Tomita, and T Ogawa, and Y Nagai, and S Kitagawa
February 1983, Journal of the National Cancer Institute,
M Saito, and H Nojiri, and H Ogino, and A Yuo, and H Ogura, and M Itoh, and K Tomita, and T Ogawa, and Y Nagai, and S Kitagawa
January 2009, Planta medica,
M Saito, and H Nojiri, and H Ogino, and A Yuo, and H Ogura, and M Itoh, and K Tomita, and T Ogawa, and Y Nagai, and S Kitagawa
July 1984, The Journal of experimental medicine,
M Saito, and H Nojiri, and H Ogino, and A Yuo, and H Ogura, and M Itoh, and K Tomita, and T Ogawa, and Y Nagai, and S Kitagawa
November 2010, Free radical research,
M Saito, and H Nojiri, and H Ogino, and A Yuo, and H Ogura, and M Itoh, and K Tomita, and T Ogawa, and Y Nagai, and S Kitagawa
May 1998, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
M Saito, and H Nojiri, and H Ogino, and A Yuo, and H Ogura, and M Itoh, and K Tomita, and T Ogawa, and Y Nagai, and S Kitagawa
January 1988, Blood,
M Saito, and H Nojiri, and H Ogino, and A Yuo, and H Ogura, and M Itoh, and K Tomita, and T Ogawa, and Y Nagai, and S Kitagawa
April 2007, Cancer research,
M Saito, and H Nojiri, and H Ogino, and A Yuo, and H Ogura, and M Itoh, and K Tomita, and T Ogawa, and Y Nagai, and S Kitagawa
November 2002, Annals of the New York Academy of Sciences,
M Saito, and H Nojiri, and H Ogino, and A Yuo, and H Ogura, and M Itoh, and K Tomita, and T Ogawa, and Y Nagai, and S Kitagawa
January 1991, Leukemia research,
M Saito, and H Nojiri, and H Ogino, and A Yuo, and H Ogura, and M Itoh, and K Tomita, and T Ogawa, and Y Nagai, and S Kitagawa
February 1987, Blood,
Copied contents to your clipboard!